Angiotensin-converting enzyme and cardiovascular disease risk.
The published studies of the association of the angiotensin-converting enzyme (ACE) genotype with cardiovascular disease have used many different diagnostic criteria for cardiovascular disease and have drawn their samples from different patient groups and different populations. This review examines the association of the ACE DD genotype with cardiovascular disease risk in studies grouped by their case criterion, the geographical region of the population samples, and by the cardiovascular risk level of the patient sample. In studies where the underlying odds ratios are determined to be homogeneous, the overall odds ratios for myocardial infarction and coronary artery disease with regard to the ACE DD genotype are estimated using the Mantel-Haenszel method.
O'Malley
J P
JP
Department of Medicine, Oregon Health Sciences University, Portland 97201, USA.
Maslen
C L
CL
Illingworth
D R
DR
D002318:Cardiovascular Diseases / Q000201:enzymology* / Q000235:genetics; D018740:Genetic Heterogeneity; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D012307:Risk Factors
D007703:Peptidyl-Dipeptidase A